Sorry, I know my stuff. I analyzed convid from day 1. And you misinterpret my words. I never said it's old, I say it's not new, as the title of this post seems to intend to convey. "2.0" Viral vector, adenovirus or AAV based, are used in gene therapy products already on the market, as well as in the J&J, AZ, and Sputnik tech, which were already put in millions of arms.
Here the information on AZ and J&J, showing you they contain DNA. Viral vector delivers this DNA to the cell nucleus, where most of our genome is located.
AZ:
"Adenoviruses such as AZD1222 are non-encapsulated, icosahedral particles (virions) between 80 and 100 nm in diameter. The particles contain a single copy of the double-stranded DNA genome."
Page 15 of the EPAR: https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf
J&J:
COVID-19 Vaccine Janssen (also referred to as Ad26.COV2.S) is a monovalent, recombinant, replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) spike (S) protein. Wild-type adenovirus serotype 26 (Ad26) consists of non-enveloped virions, which encode the adenoviral proteins. The dsDNA molecule is encapsulated by an icosahedral protein structure.
Sorry, I know my stuff. I analyzed convid from day 1. And you misinterpret my words. I never said it's old, I say it's not new, as the title of this post seems to intend to convey. "2.0" Viral vector, adenovirus or AAV based, are used in gene therapy products already on the market, as well as in the J&J, AZ, and Sputnik tech, which were already put in millions of arms.
Here the information on AZ and J&J, showing you they contain DNA. Viral vector delivers this DNA to the cell nucleus, where most of our genome is located.
AZ:
"Adenoviruses such as AZD1222 are non-encapsulated, icosahedral particles (virions) between 80 and 100 nm in diameter. The particles contain a single copy of the double-stranded DNA genome."
Page 15 of the EPAR: https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf
J&J:
COVID-19 Vaccine Janssen (also referred to as Ad26.COV2.S) is a monovalent, recombinant, replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) spike (S) protein. Wild-type adenovirus serotype 26 (Ad26) consists of non-enveloped virions, which encode the adenoviral proteins. The dsDNA molecule is encapsulated by an icosahedral protein structure.